Digital multimodal weight loss program - Randomized controlled evaluation of a digital health application for individuals with obesity - MOOSE trial

ifeness AS0 个研究点目标入组 248 人开始时间: 2024年3月19日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Confirmed diagnosis of obesity with BMI =30 and <40kg/m2
•E66.00 Obesity due to excess calories Grade 1 obesity (WHO) in patients aged 18 and over
•E66.01 Obesity due to excess calories Grade 2 obesity (WHO) in patients aged 18 and over
•- Individuals who are capable of giving their consent
•- Smartphone owned and physical as well as psychological and cognitive abilities to use the smartphone
•- Internet access for the app application and questionnaire response
•- Motivation to use the app regularly
•- Email address for registration
•- Willingness to participate in the collection of data
•- Possession of an own scale for weight measurement
•- Sufficient knowledge of the German language

•- Secondary obesity due to known endocrine or neurological disorders
•- Severe physical comorbidities, physical limitations or other medical conditions that do not allow moderate independent physical activity
•- History of severe psychiatric illness with suicide attempt
•- Currently diagnosed severe psychiatric illness with considerable strain or limitations in everyday life due to mental illness or mental problems
•- Currently ongoing psychotherapeutic treatment
•- Pregnancy or breast feeding or planned pregnancy within the next 12 months
•- History of surgical or minimally invasive weight reduction procedure or planned procedure within the interventional period
•- Current usage of the Lifeness App or comparable digital or non-digital weight management programs or usage of such in the last 3 months and = 3% weight loss in the last 3 months
•- Started with medication that affects weight within the last 3 month or planned use in the next 12 months (e.g., weight loss medication (e.g., semaglutide), specific insulin, specific antidepressant drugs)
•- Contraindications of the medical device
•Current pregnancy
•Presence of secondary forms of obesity (Cushing syndrome, Prader-Willi syndrome, hypogonadism, etc.)
•Presence of hypothyroidism if not treated with medication in advance
•Lack of change resources

发起方

ifeness AS